Flywhee.io offers a platform that uses artificial intelligence for medical imaging, aimed at scientists and researchers in healthcare and life sciences. The platform automates research workflows, allowing users to focus on discoveries rather than data management. It provides cloud-based medical image analysis software that scales on demand, which is beneficial for medical AI companies. Flywhee.io's goal is to streamline data management in research, enhancing the efficiency of the discovery process.

iSelect

dRx Capital

Argonautic Ventures

Beringea

Great North Labs

Intuitive Ventures

iSelect Fund

HP Enterprise

Seraph Group

Spike Ventures

Great North Ventures

Key Fund

Intuitive VC

Bill & Melinda Gates Foundation

Invenshure

Microsoft

Novalis Lifesciences

NVentures

SERAPH

Gundersen Health System

AI & Machine Learning

Healthcare

Flywhee.io

A Minneapolis-based med-tech software firm that's been backed by Nvidia Corp., Novalis Lifesciences and Microsoft recently raised $20 million.

Startup Flywheel raises $20 million for managing medical image data

Voximetry has partnered with Flywheel, a medical imaging AI platform powering healthcare innovation through streamlined data management, curation and analysis, the company announced recently.

Voximetry, Flywheel to Partner

MINNEAPOLIS, May 24, 2024 /PRNewswire/ -- Flywheel Exchange, Inc, the leading medical imaging data management and AI enablement company, today announced the appointment of Hooman Hakami as Interim CEO, effective immediately. Hooman will serve as Interim CEO until a long-term CEO is hired and successfully onboarded. Flywheel is currently conducting an extensive search for a long-term CEO to drive its next phase of growth in developing the leading end-to-end platform to manage and operationalize medical imaging data securely and efficiently at scale.Hooman is a seasoned executive with 30 years of business leadership experience in healthcare. Prior to Flywheel, Hooman co-founded Forte Health Advisors, a specialized healthcare advisory firm enabling innovators to transform healthcare. Previously, Hooman served in executive business roles at GE Healthcare and Medtronic, including serving on Medtronic's Executive Committee. Hooman has held multiple leadership roles throughout his career, including as President of GE's X-Ray product portfolio and Executive Vice President of Medtronic's Diabetes Group."Flywheel's Board is delighted to appoint Hooman as Interim CEO," said Marijn Dekkers, Flywheel Board Member and Chairman of Novalis LifeSciences

Flywheel Announces Hooman Hakami To Interim Ceo Appointment

Medical imaging data management vendor Flywheel announced Monday that Jim Olson is stepping down from his role as CEO and board member, effective May 1.

New CEOs joining Envision Healthcare, Iowa Radiology while top execs exit at GE HealthCare, Flywheel

MINNEAPOLIS, April 15, 2024 /PRNewswire/ -- Flywheel Exchange, Inc, the leading medical imaging data management and AI enablement company, today announced a leadership transition plan with Jim Olson stepping down from his role as CEO and Board Member, effective May 1, 2024. Colby Moosman, Flywheel's CFO, will serve as interim President to help manage the transition. Jim will continue to serve Flywheel in an advisory role to assist with the leadership transition. Flywheel has begun a search for a long-term CEO to drive its next phase of growth in developing the leading end-to-end platform to manage and operationalize medical imaging data securely and efficiently at scale."Not an easy decision, but I am stepping down as Flywheel CEO to allow a new experienced leader to drive Flywheel's next phase of growth," said Jim Olson. "It has been a great honor to lead Flywheel to this point, and I am extremely proud of what the talented Flywheel team has accomplished. Flywheel is still in the early stages of its journey -- transforming healthcare innovation by empowering organizations to efficiently and securely manage and operationalize medical imaging data for accelerated research and AI development

Flywheel Announces Leadership Transition

BOSTON--(BUSINESS WIRE)--Velsera, a global healthcare technology company that offers leading biomedical data analysis platforms, has joined forces with Flywheel, the leading medical imaging management and artificial intelligence (AI) development platform, and the Center for Data-Driven Discovery in Biomedicine (D3b) based at Children’s Hospital of Philadelphia, to advance the analysis of large-scale genomics and medical imaging datasets. In this collaborative pilot effort through the NIH-wide INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project, the partners combined their expertise to unite the Velsera CAVATICA platform and the Flywheel Core Platform, providing unprecedented capabilities to scale multimodal data analysis with clear pathways to advance precision medicine programs across government and pharmaceutical sectors. While extensive amounts of genomic and imaging data are being amassed in the healthcare system today, researchers struggle to combine this data in ways that could help make the discovery of new treatments faster and more precise. Limitations include access obstacles, privacy concerns, and integration and computational requirements for such large datasets. Combining their capabilities, Velsera, Flywheel, and D3b were able to manage, harmonize, and analyze large datasets in a cloud-based platform.The Velsera team created interoperability standards that allow platforms to communicate with each other and make large-scale data access transparent to the user. These interoperability standards make 14 PB of data accessible from the Velsera platform ecosystem.The Flywheel platform uses containerized algorithms to de-identify images, run QC workflows, and consistently curate data to facilitate large-scale sharing and analysis of imaging data sets.The D3b team provided vision of AI and imaging data, subject matter expertise in health data and bioinformatics analysis pipelines, and, within the NIH-funded INCLUDE Data Coordinating Center and Office of Data Science Strategy, FHIR proficiency critical for data harmonization.“Linking our Flywheel Core Platform with Velsera’s CAVATICA platform facilitates an unparalleled ability to perform advanced, multimodal data analysis in a cloud environment,” said Travis Richardson, Chief Strategist at Flywheel

Velsera And Flywheel Team Up To Support Multimodal Imaging Genomics Research

REDMOND, Wash., March 18, 2024 /PRNewswire/ -- Microsoft Corp. is expanding its collaboration with NVIDIA to bring the power of generative AI, the cloud and accelerated computing to healthcare and life sciences organizations. The collaboration will bring together the global scale, security and advanced computing capabilities of Microsoft Azure with NVIDIA DGX Cloud and the NVIDIA Clara suite of computing platforms, software and services to help healthcare and life sciences organizations accelerate innovation and improve patient care. Harnessing the immense power of the cloud, cutting-edge AI and advanced computing capabilities, the collaboration aims to accelerate clinical research and drug discovery, enhance medical image-based diagnostic technology, and increase access to precision medicine."Microsoft is building on its longstanding collaboration with NVIDIA to empower the healthcare and life sciences industry with the power of Azure and generative AI, helping unlock new horizons for clinical research, drug discovery and patient care worldwide," said Peter Durlach, corporate vice president, Health & Life Sciences, Microsoft. "Through this collaboration, we aim to help the industry unlock breakthroughs in healthcare, making care more precise, accessible and effective to deliver a meaningful difference in the lives of patients globally.""The convergence of AI, cloud computing and healthcare is set to transform patient care," said Kimberly Powell, vice president of healthcare, NVIDIA. "Our collaboration with Microsoft will help unlock new possibilities and drive meaningful impact for patients worldwide."The expanded collaboration will extend opportunities for healthcare providers, pharmaceutical and biotechnology companies, and medical device developers to innovate rapidly across clinical research, drug discovery and care delivery with improved efficiency and effectiveness.Faster drug discovery with NVIDIA BioNeMo on NVIDIA DGX Cloud, hosted on Microsoft AzureHosted on NVIDIA DGX Cloud on Azure, NVIDIA BioNeMo offers the quickest path to AI model development and deployment, accelerating the journey to AI-powered drug discovery

Microsoft Announces Collaboration With Nvidia To Accelerate Healthcare And Life Sciences Innovation With Advanced Cloud, Ai And Accelerated Computing Capabilities

Omnicom closes the acquisition of Flywheel.

Omnicom Closes the Acquisition of Flywheel

What You Should Know:Flywheel, a medical imaging artificial intelligence (AI) development platform, today announced the launch of its software-as-a-service (SaaS) data management solution on Microsoft Azure. This new SaaS offering will provide healthcare organizations with a secure, scalable, and user-friendly platform to manage, curate, and analyze their medical imaging data.Flywheel’s SaaS solution is integrated with NVIDIA MONAI, part of the NVIDIA AI Enterprise software platform, and Azure Machine Learning Studio for the development and deployment of production-grade AI applications. This integration will make it easier for healthcare organizations to develop and deploy AI models that can be used to improve patient care.Overcoming Barriers to Medical Imaging BreakthroughsHealthcare breakthroughs have long been hindered by the difficulty of managing and analyzing medical imaging data. This data is often unstructured and siloed, making it difficult to access and use. Flywheel’s SaaS solution will help healthcare organizations overcome these barriers and accelerate the development of new AI applications for medical imaging.Key Features of Flywheel’s SaaS SolutionSecure and scalable: Flywheel’s SaaS solution is hosted on Microsoft Azure, which provides a secure and scalable platform for managing and analyzing medical imaging data.Flywheel’s SaaS solution is hosted on Microsoft Azure, which provides a secure and scalable platform for managing and analyzing medical imaging data. User-friendly: Flywheel’s SaaS solution is designed to be easy to use for healthcare professionals, even those with no prior experience with AI.Flywheel’s SaaS solution is designed to be easy to use for healthcare professionals, even those with no prior experience with AI

Flywheel'S Ai Platform Takes Flight With Microsoft Azure And Nvidia

Flywheel, a leading medical imaging artificial intelligence (AI) development platform, announced the launch of its software-as-a-service (SaaS) data management solution on Microsoft Azure.

Flywheel Collaborates with Microsoft and NVIDIA to Propel End-to-End AI Development Platform on Microsoft Azure

AI platform for medical imaging workflows

Flywhee.io

AI platform for medical imaging workflows

Flywhee.io

AI platform for medical imaging workflows

About

Simplify's Take

What believers are saying

What critics are saying

What makes Flywhee.io unique

6 month growth

1 year growth

2 year growth

Recently Posted Jobs

Flywhee.io is Hiring for 0 Jobs on Simplify!